Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-o
Patent
1993-06-18
1994-12-27
Bhat, Nina
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-o
436128, 436161, G01N 3320
Patent
active
053765532
ABSTRACT:
Dicitrate cyclic diester (dicitrate) is a novel compound which is found in patients who do not exhibit symptoms or predisposition to idiopathic renal calculous disease. Dicitrate can be isolated and detected by novel chromatographic methods. Further, treating patients prophylactically and therapeutically with dicitrate cyclic diester can prevent or reduce the effects of calcification-related disease, including some types of kidney stones.
REFERENCES:
patent: 4399003 (1983-08-01), Sarig et al.
patent: 4814177 (1989-03-01), Walsdorf et al.
patent: 4851221 (1989-07-01), Pak et al.
patent: 4888182 (1989-12-01), Pak
patent: 5075499 (1991-12-01), Walsdorf et al.
patent: 5137722 (1992-08-01), Costello
Boyce, William H. (1979) "Epidemiology of Lithiasis in the United States" XVIIIth C.M. Congress of the International Society of Urology, Paris Kongressbericht, Tome 1, pp. 79-86.
Sierakowski, Robert, Birdwell Finlayson, Ralph R. Landes, Carol D. Finlayson, and Nina Sierakowski (1978) "The Frequency of Urolithiasis in Hospital Discharge Diagnosis in the United States" Investigative Urology 15(6):438-441.
Davis, George K., Nancy B. Cummings, Birdwell Finlayson, John L. Meyer, and M. J. Vernon Smith "Urolithiasis" Geochemistry and the Environment, Nat. Acad. Sci., Washington, pp. 133-138.
Thomas, Jr., William C. (1976) Renal Calculi: A Guide to Management, Charles C. Thomas, Publisher, Springfield, Ill., p. 171.
Coe, Fredric L., Y. Nakagawa, and J. H. Parks (1991) "Inhibitors Within the Nephron" American Journal of Kidney Disease 17(4):407-413.
Azoury, R., J. Ramon, S. Abrashkin, J. Shalev, and B. Goldwasser (1990) "Hydration feature of urinary compounds" Urological Research 18(7):7-11.
Schrier, E. E., Karen E. Lee, J. L. Rubin, P. G. Werness, and L. H. Smith (1979) "Macromolecular inhibitors of calcium oxalate crystal growth and aggregation in urine" Oxalate in Human Biochemistry and Clinical Pathology, G. A. Rose et al. [eds.] London, The Welcome Foundation, pp. 22-61.
Thomas, William C., Jr. (1988) "Kidney Stones, Urine, and Cement" MMJ 37(11):861-862.
Zhmurov, V. A., N. I. Kazeko, G. Ya. Perker, V. E. Tsvettsikh, and V. R. Sultanbaev (1991) "Parameters of Destabilized Cellular Membranes and Urolithiasis" Urol. Nefrol-Moscow May-Jun. (3):12-15.
Batich Christopher D.
Purich Daniel L.
Thomas, Jr. William C.
Bhat Nina
University of Florida
LandOfFree
Clinical marker and therapeutic agent in kidney stone disease an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clinical marker and therapeutic agent in kidney stone disease an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clinical marker and therapeutic agent in kidney stone disease an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918840